scholarly journals Coupling of D2 dopamine receptors to G-proteins in solubilized preparations of bovine caudate nucleus

1992 ◽  
Vol 281 (2) ◽  
pp. 369-375 ◽  
Author(s):  
J A Chazot ◽  
P G Strange

1. The coupling of D2 dopamine receptors and G-proteins has been examined in cholate-solubilized preparations of bovine caudate nucleus. 2. No receptor-G-protein coupling could be detected in solubilized preparations obtained in 0.3% cholate, but if this preparation is diluted 5-fold, coupling is re-established. 3. The dilution process was examined, and it was shown that the change in ionic strength was an important factor in modulating the observed receptor-G-protein interaction. 4. Ionic strength was shown, however, not to be the primary determinant of receptor-G-protein coupling. This is likely to be the formation, upon dilution of the preparation, of vesicles in which receptor and G-protein reassociate. 5. The formation of vesicles upon dilution was examined by a variety of techniques, including thermal-stability studies, gel filtration, centrifugation and electron microscopy.

2008 ◽  
Vol 325 (1) ◽  
pp. 319-330 ◽  
Author(s):  
J. Robert Lane ◽  
Ben Powney ◽  
Alan Wise ◽  
Stephen Rees ◽  
Graeme Milligan

2006 ◽  
Vol 6 (1) ◽  
pp. 1-16 ◽  
Author(s):  
Ganga D. Ghimire ◽  
Kenichiro Imai ◽  
Fumitsugu Akazawa ◽  
Toshiyuki Tsuji ◽  
Masashi Sonoyama ◽  
...  

Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 1557-1557
Author(s):  
Jin-Sheng Huang ◽  
Lanlan Dong ◽  
Guy C. Le Breton

Abstract We have previously demonstrated in human platelets that G-protein coupled receptors (GPCRs) which share a common G” subunit have the capacity to cross-signal when exposed to their respective ligands. This ligand-dependent cross-signaling was shown to involve a redistribution of GPCR-coupled G” subunits, a consequent shift in GPCR ligand affinity and a synergistic effector response (Djellas, et al. 1998; PNAS,95:10944 and Djellas, et al. 2000; Biochem.Pharmacol.59:1521). Based on these findings, we proposed that the phenomenon of ligand-dependent cross-signaling represents one manifestation of a more general process by which cells can dynamically regulate their different GPCR signaling priorities in response to various stimuli. In this model, the relative signaling capacity through different GPCRs is determined by the distribution of G proteins amongst the different GPCRs at a given point in time. The model further predicts that this G protein distribution is not only modulated by ligand-induced shifts in GPCR:G protein coupling affinities (ligand-dependent cross-signaling), but also by shifts in GPCR:G protein mass ratios (mass-dependent cross-signaling), such as those that may occur by up- or down-regulation of GPCRs or their respective G protein partners. The present study examined this mass-dependent GPCR cross-signaling process. Specifically, we established a series of cell lines in which the expression levels of thromboxane A2 receptors (TPR) and platelet activating factor receptors (PAFR) can be progressively altered. These expression systems allowed an alteration of the GPCR:G protein mass ratio for specific GPCRs, i.e., TPR and PAFR. Using radioligand binding analysis and Western blot, we provide evidence that up-regulating TPR expression levels increased the TPR:G-protein mass ratio. This TPR up-regulation resulted in a reduced TPR ligand affinity for [3H] SQ29548. Thus increasing the mass of TPR relative to its G protein partners (Gq or G13) shifted TPRs to a lower ligand affinity state. A similar reduction in PAFR ligand affinity was observed when the PAFR:G-protein mass ratio was increased by elevating PAFR expression levels. Moreover, using an inducible TPR/PAFR co-expressing cell line, increasing the expression level of one of the receptors resulted in reduced ligand affinity for both receptors. Taken in combination with our previous studies, these findings suggest that increasing TPR: G protein mass ratio results in a shift in the TPR-G protein coupling status, such that a larger fraction of total TPR is in the uncoupled state. This reduction in TPR-G protein coupling in turn leads to lower TPR ligand affinity. The finding that expression of TPR also causes reduced ligand affinity for a separate GPCR, i.e. PAFR, suggests that there is a dynamic equilibrium between the distribution of G proteins amongst GPCRs, and that this equilibrium can be altered by changes in the GPCR: G protein mass ratio. In summary, both ligand-dependent and mass-dependent GPCR cross-signaling appear to result from a general mechanism by which cells modulate their GPCR-G protein coupling status, and hence their GPCR ligand affinities and signaling priorities.


2000 ◽  
Vol 348 (3) ◽  
pp. 531-537 ◽  
Author(s):  
Neil T. BURFORD ◽  
Danxin WANG ◽  
Wolfgang SADÉE

To determine μ-opioid receptor (OP3) signalling activity, guanosine 5ʹ-[γ-[35S]thio]triphosphate (GTP[35S]) binding to G-proteins was measured in the membranes of human embryonic kidney cells (HEK-293) transfected with μ-opioid receptor (HEK-μ). GTP[35S] binding to HEK-μ membranes was significantly elevated compared with HEK-293 control membranes (without OP3), and this was abolished by pertussis-toxin pretreatment. The irreversible antagonist β-chlornaltrexamine (β-CNA) dose-dependently decreased elevated basal G-protein coupling of HEK-μ to control levels in cells devoid of OP3. This characterizes β-CNA as an inverse OP3 agonist. Immunoprecipitation of solubilized G-proteins with Gi3α antisera demonstrated that basal GTP[35S] binding to Gi3α was also substantially elevated in HEK-μ membranes over the control, whereas Gi3α protein levels were unchanged. Basal GTP[35S] binding to Gi1α/Gi2α and Goα was also increased twofold in HEK-μ membranes over the control. Morphine further increased coupling to each of these Gα proteins with similar potency, but not to Gq/11α or Gsα. These results indicate that the wild-type OP3 can couple constitutively to endogenously expressed Gi3α, Gi1α/Gi2α and Goα subunits of G-proteins in HEK-293 cells.


Sign in / Sign up

Export Citation Format

Share Document